Heart Attack Patient Costs Skyrocket Beyond 30 Days
Likosky says that the research period did not extend beyond 2008, when new payment policies from the Centers for Medicare & Medicaid Services attempted to reign in ambulatory spending for imaging, and benefits for hospice care were limited.
In an accompanying commentary, Ashish Jha, MD, professor of health policy and management at the Harvard School of Public Health, noted that "the additional spending went toward paying for more skilled nursing facilities, physician's visits, home health care, and durable medical equipment. Although readmission rates in the late period remained stable, the spending per readmission went up—with little evidence that patients benefited."
Jha also noted that not only are these post-acute episode services expensive to Medicare "but to the beneficiaries as well," prompting them to incur "substantial out-of-pocket costs."
Likosky's report, Jha wrote, "should be a wake-up call for federal policy makers" to focus on cost reductions beyond 30 days, and is "a timely reminder of the importance of research and data for policy making."
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers